Hamburger Hafen und Logistik AG
- WKN: A0S848
- ISIN: DE000A0S8488
- Land: Deutschland
Nachricht vom 20.10.2021 | 10:30
Hamburger Hafen und Logistik AG: HHLA raises forecast for financial year 2021
Hamburger Hafen und Logistik AG / Key word(s): Forecast/Change in Forecast
Hamburg, Germany, 20 October 2021
Hamburger Hafen und Logistik Aktiengesellschaft
HHLA raises forecast for financial year 2021
Hamburger Hafen und Logistik AG (HHLA) is raising its forecast for revenue and EBIT in the current fiscal year based on preliminary figures for the company's performance during the first nine months of the year. Extraordinary, non-recurring earnings effects in the Port Logistics subgroup were a significant factor in adjusting the annual forecast. In contrast to original assumptions, the ongoing disruptions in global supply chains and the associated massive ship delays also led to temporary significantly higher storage fees in the third quarter as a result of longer container dwell times at HHLA's terminals in Hamburg. In addition, a higher subsidy for route prices of € 11 million granted retroactively for 2020 by the German Federal Railway Authority made a positive contribution to the Port Logistics subgroup's earnings.
For the Port Logistics subgroup, a moderate increase in container throughput is expected again, as is a significant increase in container transport compared to the previous year. HHLA now expects revenue for the 2021 financial year to come to around € 1,410 million (previously: significant increase compared to the previous year). Against the background of the aforementioned extraordinary earnings effects, the forecast for the operating result (EBIT) of the Port Logistics subgroup is being raised and will come to around € 190 million (previously: range of € 140 million to € 165 million).
The revenue and operating result (EBIT) of the Real Estate subgroup are expected to be on a par with the previous year's level (previously: slight increase in revenue).
At the Group level, a strong increase in revenue compared to the previous year is expected. Revenue is expected to come to around € 1,450 million. The forecast for the Group operating result (EBIT) was raised in response to the positive developments in the Port Logistics subgroup and is now at around € 205 million (previously: range of € 153 million to € 178 million).
In the current financial year, planned asset additions for investments to further increases in productivity in the Container and Intermodal segments will be delayed until 2022 as a result of the ongoing disruptions in global supply chains. Investments of € 200 million are now expected at the Group level for 2021 (previously: range of € 250 to € 280 million). Around € 175 million of this is attributed to the Port Logistics subgroup (previously: € 220 million to € 250 million).
HHLA will publish complete figures for January to September 2021 on Thursday, 11 November 2021, at 7.30 a.m.
EBIT is defined as earnings before interest and taxes. For more detailed information, please click here.
Head of Investor Relations
HAMBURGER HAFEN UND LOGISTIK AG
Bei St. Annen 1, D-20457 Hamburg, www.hhla.de
|Company:||Hamburger Hafen und Logistik AG|
|Bei St. Annen 1|
|Listed:||Regulated Market in Frankfurt (Prime Standard), Hamburg; Regulated Unofficial Market in Berlin, Dusseldorf, Hanover, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||1242055|
|End of Announcement||DGAP News Service|
Hamburger Hafen und Logistik AG: HHLA's revenu ...
Hamburger Hafen und Logistik AG: HHLA raises f ...
Hamburger Hafen und Logistik AG: Tollerort to ...
Hamburger Hafen und Logistik AG: HHLA benefits ...
Hamburger Hafen und Logistik AG: Release accor ...
GBC im Fokus
IGEA Pharma N.V. Realignment to CBD extraction
The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.
Der AKTIONÄR News
29. November 13:10 Bayer: Das sieht übel aus - so schlimm kann es jetzt werden
29. November 13:20 Tipp der Woche: Etsy mit Aufwärtstrend aus dem Bilderbuch
29. November 13:50 Nur noch wenige Stunden: 25% Rabatt auf Highflyer wie Lloyd Fonds, ...
29. November 14:04 Neue Corona-Sorgen - Moderna hebt ab
29. November 14:21 Siemens Healthineers: Neue Test-Power für den Highflyer - hier ...
Original-Research: Gold Mountain Mining Corp. (von hanseatic stock publishing UG (haftungsbeschränkt)): Gold Mountain Mining Corp.
29. November 2021